Literature DB >> 30051411

Genome-Wide Association Studies and Risk Scores for Coronary Artery Disease: Sex Biases.

Sean G Byars1,2, Mike Inouye3,4,5.   

Abstract

Phenotypic sex differences in coronary artery disease (CAD) and its risk factors have been apparent for many decades in basic and clinical research; however, whether these are also present at the gene level and thus influence genome-wide association and genetic risk prediction studies has often been ignored. From fundamental and medical standpoints, this is critically important to assess in order to fully understand the underlying genetic architecture that predisposes to CAD and better predict disease outcomes based on the interaction between genes, sex effects, and environment. In this chapter we aimed to (1) integrate the history and latest research from genome-wide association studies for CAD and clinical and genetic risk scores for prediction of CAD, (2) highlight sex-specific differences in these areas of research, and (3) discuss reasons why sex differences have often not been considered and, where present, why sex differences exist at genetic and phenotypic levels and how important they are for consideration in future research. While we find interesting examples of sex differences in effects of genetic variants on CAD, genome-wide association and genetic risk studies have typically not tested for sex-specific effects despite mounting evidence from diverse fields that these are likely very important to consider at both the genetic and phenotypic levels. In-depth testing for sex effects in large-scale genome-wide association studies that include autosomal and often excluded sex chromosomes alongside parallel improvements in resolution of sex-specific differences for risk factors and disease outcomes for CAD has the potential to substantially improve clinical and genetic risk prediction studies. Developing sex-tailored genetic risk scores as has been done recently for other disorders might be also warranted for CAD. In the era of precision medicine, this level of accuracy is essential for such a common and costly disease.

Entities:  

Keywords:  Coronary risk factors; GWAS; Genetic risk score; Sex-specific analysis; Single nucleotide polymorphism; Women’s Genome Health Study

Mesh:

Substances:

Year:  2018        PMID: 30051411     DOI: 10.1007/978-3-319-77932-4_38

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Identification of molecular mechanisms underlying the therapeutic effects of Xintong granule in coronary artery disease by a network pharmacology and molecular docking approach.

Authors:  Zhihong Huang; Siyu Guo; Changgeng Fu; Wei Zhou; Antony Stalin; Jingyuan Zhang; Xinkui Liu; Shanshan Jia; Chao Wu; Shan Lu; Bingbing Li; Zhishan Wu; Yingying Tan; Xiaotian Fan; Guoliang Cheng; Yanfang Mou; Jiarui Wu
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

Review 2.  Ageing, sex, and cardioprotection.

Authors:  Marisol Ruiz-Meana; Kerstin Boengler; David Garcia-Dorado; Derek J Hausenloy; Tuuli Kaambre; Georgios Kararigas; Cinzia Perrino; Rainer Schulz; Kirsti Ytrehus
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

3.  Heterogeneity of the Predictive Polygenic Risk Scores for Coronary Heart Disease Age-at-Onset in Three Different Coronary Heart Disease Family-Based Ascertainments.

Authors:  Mary F Feitosa; Allison L Kuipers; Mary K Wojczynski; Lihua Wang; Emma Barinas-Mitchell; Alexander M Kulminski; Bharat Thyagarajan; Joseph H Lee; Thomas Perls; Kaare Christensen; Anne B Newman; Joseph M Zmuda; Michael A Province
Journal:  Circ Genom Precis Med       Date:  2021-04-12

Review 4.  Relationships between Psychoeducational Rehabilitation and Health Outcomes-A Systematic Review Focused on Acute Coronary Syndrome.

Authors:  Sabina Alexandra Cojocariu; Alexandra Maștaleru; Radu Andy Sascău; Cristian Stătescu; Florin Mitu; Elena Cojocaru; Laura Mihaela Trandafir; Maria-Magdalena Leon-Constantin
Journal:  J Pers Med       Date:  2021-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.